Expertise

My 20+ year career in the pharmaceutical industry has provided me with extensive expertise across more than 10 therapeutic areas – from cardiology & diabetes (ARBs, SGLT2, DPP-4) to pulmonary arterial hypertension (PAH), oncology, gastroenterology, urology, to innovative pain management (orphan drugs & opioids), transplantation (tacrolimus), anti-infectives, and generic substitution. I have a broad background in working with Rx products (Rx), orphan drugs, biosimilars, medical devices and OTC and I have successfully designed and implemented sales strategies in retail and hospital markets.

My achievements include the successful relaunch of the generic medicines division at Mundipharma Austria and the launch of PELMEG (the first biosimilar to NEULASTA) in Austria and France. As Alliance Lead for Central Eastern Europe & Emerging Markets at Mundipharma, I developed partnerships in Russia, Romania, the Baltic States and the Adriatic Region. This background makes us the ideal partner for complex challenges in primary care, specialty care, and beyond. As Director Corporate Alliances at AOP Health, I was commercially responsible for 13 partner markets, including region LATAM and Australia.